Pro-Dex (PDEX) Competitors $36.39 +0.82 (+2.31%) Closing price 04:00 PM EasternExtended Trading$36.39 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PDEX vs. AVNS, KIDS, ZIMV, TMCI, SMLR, CBLL, BFLY, DCTH, RXST, and SNWVShould you be buying Pro-Dex stock or one of its competitors? The main competitors of Pro-Dex include Avanos Medical (AVNS), OrthoPediatrics (KIDS), ZimVie (ZIMV), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Butterfly Network (BFLY), Delcath Systems (DCTH), RxSight (RXST), and Sanuwave Health (SNWV). These companies are all part of the "medical equipment" industry. Pro-Dex vs. Its Competitors Avanos Medical OrthoPediatrics ZimVie Treace Medical Concepts Semler Scientific CeriBell Butterfly Network Delcath Systems RxSight Sanuwave Health Pro-Dex (NASDAQ:PDEX) and AVANOS MEDICAL (NYSE:AVNS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends. Does the media refer more to PDEX or AVNS? In the previous week, Pro-Dex and Pro-Dex both had 3 articles in the media. AVANOS MEDICAL's average media sentiment score of 1.75 beat Pro-Dex's score of -0.24 indicating that AVANOS MEDICAL is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral AVANOS MEDICAL 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more volatility & risk, PDEX or AVNS? Pro-Dex has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500. Comparatively, AVANOS MEDICAL has a beta of 1.12, suggesting that its stock price is 12% more volatile than the S&P 500. Do insiders & institutionals hold more shares of PDEX or AVNS? 15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 95.2% of AVANOS MEDICAL shares are owned by institutional investors. 47.5% of Pro-Dex shares are owned by company insiders. Comparatively, 2.6% of AVANOS MEDICAL shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, PDEX or AVNS? Pro-Dex has higher earnings, but lower revenue than AVANOS MEDICAL. AVANOS MEDICAL is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPro-Dex$66.59M1.78$8.98M$2.7013.48AVANOS MEDICAL$687.80M0.83-$392.10M-$10.07-1.23 Do analysts recommend PDEX or AVNS? Pro-Dex currently has a consensus price target of $56.00, suggesting a potential upside of 53.89%. Given Pro-Dex's stronger consensus rating and higher probable upside, analysts clearly believe Pro-Dex is more favorable than AVANOS MEDICAL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pro-Dex 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00AVANOS MEDICAL 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is PDEX or AVNS more profitable? Pro-Dex has a net margin of 13.48% compared to AVANOS MEDICAL's net margin of -66.89%. Pro-Dex's return on equity of 26.67% beat AVANOS MEDICAL's return on equity.Company Net Margins Return on Equity Return on Assets Pro-Dex13.48% 26.67% 14.95% AVANOS MEDICAL -66.89%6.16%4.57% SummaryPro-Dex beats AVANOS MEDICAL on 11 of the 15 factors compared between the two stocks. Get Pro-Dex News Delivered to You Automatically Sign up to receive the latest news and ratings for PDEX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDEX vs. The Competition Export to ExcelMetricPro-DexMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$118.70M$15.19B$5.81B$10.03BDividend YieldN/A1.49%6.67%4.54%P/E Ratio13.4817.6175.7526.29Price / Sales1.782.24449.5181.86Price / Cash12.1813.8525.7029.20Price / Book3.243.4511.506.43Net Income$8.98M$472.94M$3.28B$270.56M7 Day Performance-20.96%-0.55%1.30%3.01%1 Month Performance-23.79%-3.01%11.25%9.74%1 Year Performance37.40%7.17%59.54%26.68% Pro-Dex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDEXPro-Dex2.8 of 5 stars$36.39+2.3%$56.00+53.9%+52.8%$118.70M$66.59M13.48140Earnings ReportAVNSAvanos Medical2.2606 of 5 stars$11.93+0.5%N/A-47.7%$554.05M$687.80M-1.192,227Positive NewsKIDSOrthoPediatrics4.4635 of 5 stars$21.36-0.4%$34.14+59.8%-31.8%$535.57M$204.73M-11.93200Positive NewsZIMVZimVie0.8807 of 5 stars$18.88-0.1%$17.75-6.0%+17.5%$532.43M$449.75M-26.971,770Positive NewsTMCITreace Medical Concepts2.7686 of 5 stars$7.34-0.8%$9.83+34.0%+33.4%$463.69M$209.36M-9.29250Positive NewsSMLRSemler Scientific3.4792 of 5 stars$29.64-3.2%$81.75+175.8%+19.7%$438.81M$56.29M12.20120Trending NewsCBLLCeriBell2.7881 of 5 stars$11.83-1.2%$32.14+171.7%N/A$433.73M$65.44M-3.96N/APositive NewsBFLYButterfly Network3.055 of 5 stars$1.62-0.9%$3.00+85.8%-2.7%$405.30M$82.06M-5.77460News CoveragePositive NewsInsider TradeDCTHDelcath Systems3.1685 of 5 stars$11.02+1.3%$24.50+122.3%+19.4%$385.49M$37.21M220.4060Positive NewsRXSTRxSight1.6074 of 5 stars$9.04-1.2%$10.00+10.6%-83.1%$369.88M$139.93M-11.30220SNWVSanuwave Health2.5568 of 5 stars$41.64-1.9%$55.00+32.1%N/A$356.77M$32.63M-5.0540News CoverageAnalyst Downgrade Related Companies and Tools Related Companies AVNS Competitors KIDS Competitors ZIMV Competitors TMCI Competitors SMLR Competitors CBLL Competitors BFLY Competitors DCTH Competitors RXST Competitors SNWV Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PDEX) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
